Files in this Data Supplement:
Supplemental Figure 1 - Changes in 8-NBD-cAMP fluorescence as a function of EPAC2 and cyclic nucleotide concentrations
Supplemental Figure 2 - Effects of ESI-09 on type I and II PKA activities
Supplemental Figure 3 - ESI-09 inhibits EPAC-mediated Akt phosphorylation in INS-1 cells
Supplemental Figure 4 - Effects of ESI-09 treatment on pancreatic cancer cell viability
Supplemental Figure 5 - Expression levels of EPAC1 and EPAC2 in the PDA cell lines PANC-1 and AsPC-1